Akèy › Kansè pankreyas › Tennessee › Memphis
Etid klinik pou Kansè pankreyas nan Memphis, TN
9 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Ap rekriteFaz 3
- West Cancer Center, Germantown · 14 mi lwen
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Ap rekriteFaz 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi lwen
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi lwen
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Ap rekriteFaz 2
- Baptist Clinical Research, Memphis
Familial Investigations of Childhood Cancer Predisposition
Ap rekriteEtid obsèvasyon
- St. Jude Children's Research Hospital, Memphis
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Ap rekriteFaz 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi lwen
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi lwen
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Ap rekriteFaz 2
- Ohio State University-Telemedicine, Memphis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Memphis
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- Exelixis Clinical Site #11, Germantown · 14 mi lwen
Etid Kansè pankreyas nan lòt vil
- Houston, TX61 etid
- New York City, NY60 etid
- Boston, MA43 etid
- Nashville, TN39 etid
- Los Angeles, CA35 etid
- St. Louis, MO33 etid
- Arlington, VA33 etid
- Baltimore, MD31 etid
- San Antonio, TX31 etid
- Philadelphia, PA26 etid
- Tampa, FL26 etid
- Durham, NC24 etid
Lòt etid nan Memphis
- Kansè (tout kalite)31 etid
- Kansè Poumon ki pa ti selil23 etid
- Kansè nan tete22 etid
- Kansè poumon18 etid
- Maladi selil fòs18 etid
- Leksemi limfoblastik egi16 etid
- Leksemi mieloïd egi15 etid
- Ensifizyans kadyak13 etid
- Sarkom tisi mou11 etid
- Melanom11 etid
- Kansè pwostat11 etid
- Kansè kolorektal11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.